{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:40:59Z","timestamp":1770504059689,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3111,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/sj.ki.5002191","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T11:33:32Z","timestamp":1177500812000},"page":"1279-1286","source":"Crossref","is-referenced-by-count":105,"title":["Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study"],"prefix":"10.1016","volume":"71","author":[{"given":"B.","family":"Kollerits","sequence":"first","affiliation":[]},{"given":"D.","family":"Fliser","sequence":"additional","affiliation":[]},{"given":"I.-M.","family":"Heid","sequence":"additional","affiliation":[]},{"given":"E.","family":"Ritz","sequence":"additional","affiliation":[]},{"given":"F.","family":"Kronenberg","sequence":"additional","affiliation":[]},{"family":"for the MMKD Study Group","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002191_bb0010","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.1987.122","article-title":"Relationship between vascular disease and age-associated changes in the human kidney","volume":"31","author":"Kasiske","year":"1987","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002191_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.me.43.020192.000503","article-title":"A putative role of hypercholesterolemia in progressive glomerular injury","volume":"43","author":"Diamond","year":"1992","journal-title":"Annu Rev Med"},{"key":"10.1038\/sj.ki.5002191_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/14779072.3.3.465","article-title":"Adiponectin: linking the metabolic syndrome to its cardiovascular consequences","volume":"3","author":"Rabin","year":"2005","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1038\/sj.ki.5002191_bb0025","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5002191_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V131134","article-title":"Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0035","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2337\/diabetes.51.7.2306","article-title":"A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome","volume":"51","author":"Menzaghi","year":"2002","journal-title":"Diabetes"},{"key":"10.1038\/sj.ki.5002191_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00125-004-1597-y","article-title":"The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study","volume":"48","author":"Costacou","year":"2005","journal-title":"Diabetologia"},{"key":"10.1038\/sj.ki.5002191_bb0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.54.2.534","article-title":"Adiponectin and future coronary heart disease events among men with type 2 diabetes","volume":"54","author":"Schulze","year":"2005","journal-title":"Diabetes"},{"key":"10.1038\/sj.ki.5002191_bb0050","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"JAMA"},{"key":"10.1038\/sj.ki.5002191_bb0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in US adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5002191_bb0060","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1681\/ASN.2005010106","article-title":"Metabolic syndrome and the risk for chronic kidney disease among nondiabetic Adults","volume":"16","author":"Kurella","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.2004090742","article-title":"Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the Mild and Moderate Kidney Disease Study","volume":"16","author":"Becker","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0070","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1681\/ASN.2005070733","article-title":"Apolipoprotein A-IV predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study","volume":"17","author":"Boes","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/039139880402701004","article-title":"The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients","volume":"27","author":"Lee","year":"2004","journal-title":"Int J Artif Organs"},{"key":"10.1038\/sj.ki.5002191_bb0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1440-1797.2005.00490.x","article-title":"Should we quantify insulin resistance in patients with renal disease?","volume":"10","author":"Shen","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1038\/sj.ki.5002191_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/eje.1.01930","article-title":"Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study","volume":"153","author":"Isobe","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 84","key":"10.1038\/sj.ki.5002191_bb0095","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1046\/j.1523-1755.63.s84.49.x","article-title":"Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors","volume":"63","author":"Zoccali","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/sj.ki.5002191_bb0100","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1210\/jc.2005-0825","article-title":"Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women","volume":"90","author":"Lawlor","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5002191_bb0105","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1161\/01.ATV.0000153090.21990.8c","article-title":"Adiponectin and coronary heart disease: the Strong Heart Study","volume":"25","author":"Lindsay","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/sj.ki.5002191_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1536\/jhj.43.85","article-title":"Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting","volume":"43","author":"Shimada","year":"2002","journal-title":"Jpn Heart J"},{"key":"10.1038\/sj.ki.5002191_bb0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/CIRCULATIONAHA.106.618918","article-title":"Adiponectin and coronary heart disease. A prospective study and meta-analysis","volume":"114","author":"Sattar","year":"2006","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5002191_bb0120","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1210\/jc.2006-0107","article-title":"Serum adiponectin and coronary heart disease risk in older black and white americans","volume":"91","author":"Kanaya","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5002191_bb0125","series-title":"Am J Epidemiol","article-title":"Association of adiponectin with coronary heart disease and mortality","author":"Laughlin","year":"2006"},{"key":"10.1038\/sj.ki.5002191_bb0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jc.2005-1117","article-title":"Adiponectin is inversely associated with renal function in type 1 diabetic patients","volume":"91","author":"Schalkwijk","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5002191_bb0135","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1210\/jc.2006-0836","article-title":"Adiponectin and mortality in patients undergoing coronary angiography","volume":"91","author":"Pilz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5002191_bb0140","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1681\/ASN.2006040331","article-title":"Adiponectin and mortality in patients with chronic kidney disease","volume":"17","author":"Menon","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.104.530972","article-title":"Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure","volume":"112","author":"Kistorp","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5002191_bb0150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm1029","article-title":"Adiponectin acts in the brain to decrease body weight","volume":"10","author":"Qi","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/sj.ki.5002191_bb0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.semnephrol.2005.09.005","article-title":"Epidemiology of dialysis patients and heart failure patients","volume":"26","author":"Kalantar-Zadeh","year":"2006","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1038\/sj.ki.5002191_bb0165","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2337\/diacare.27.9.2217","article-title":"Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes","volume":"27","author":"Furuhashi","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1038\/sj.ki.5002191_bb0170","doi-asserted-by":"crossref","first-page":"19521","DOI":"10.1074\/jbc.M200601200","article-title":"Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002191_bb0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000441-200512000-00004","article-title":"Epidemiology of the metabolic syndrome","volume":"330","author":"Reynolds","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1038\/sj.ki.5002191_bb0180","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/db05-1272","article-title":"Sex-discordant associations with adiponectin levels and lipid profiles in children","volume":"55","author":"Ong","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/sj.ki.5002191_bb0185","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications for metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002191_bb0190","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00125-005-1876-2","article-title":"The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"48","author":"Kahn","year":"2005","journal-title":"Diabetologia"},{"key":"10.1038\/sj.ki.5002191_bb0195","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.2337\/db06-0271","article-title":"Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene","volume":"55","author":"Vionnet","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/sj.ki.5002191_bb0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2337\/diabetes.55.02.06.db05-0747","article-title":"Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1727 healthy Caucasians","volume":"55","author":"Heid","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/sj.ki.5002191_bb0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1681\/ASN.V111105","article-title":"Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure","volume":"11","author":"Kronenberg","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0210","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1097\/01.ASN.0000022011.35035.F3","article-title":"Predicitive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels","volume":"13","author":"Bostom","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002191_bb0215","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815522928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815522928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T21:43:29Z","timestamp":1628804609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815522928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0085253815522928"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002191","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}